Helen Voelker
Overview
Explore the profile of Helen Voelker including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
20
Citations
289
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
LaFon D, Helgeson E, Lindberg S, Voelker H, Bhatt S, Casaburi R, et al.
JAMA Netw Open
. 2024 May;
7(5):e247535.
PMID: 38771577
Importance: While β-blockers are associated with decreased mortality in cardiovascular disease (CVD), exacerbation-prone patients with chronic obstructive pulmonary disease (COPD) who received metoprolol in the Beta-Blockers for the Prevention of...
2.
Wade R, Ling S, Helgeson E, Voelker H, Labaki W, Meza D, et al.
Chronic Obstr Pulm Dis
. 2023 Nov;
11(1):101-105.
PMID: 37963303
Introduction: In 2019, the Beta-Blockers for the Prevention of Acute Exacerbations of Chronic Obstructive Pulmonary Disease study (BLOCK-COPD) evaluated the effect of metoprolol on exacerbation risk and mortality in a...
3.
Wade R, Mkorombindo T, Ling S, Helgeson E, MacDonald D, Pew K, et al.
BMC Pulm Med
. 2023 Nov;
23(1):434.
PMID: 37946165
Rationale: Pulmonary hypertension (PH) in COPD confers increased risk of exacerbations (ECOPD). Electrocardiogram (ECG) indicators of PH are prognostic both in PH and COPD. In the Beta-Blockers for the Prevention...
4.
Albert R, Jurkovich G, Connett J, Helgeson E, Keniston A, Voelker H, et al.
JAMA
. 2023 Oct;
330(20):1982-1990.
PMID: 37877609
Importance: Among patients receiving mechanical ventilation, tidal volumes with each breath are often constant or similar. This may lead to ventilator-induced lung injury by altering or depleting surfactant. The role...
5.
MacDonald D, Mkorombindo T, Ling S, Adabag S, Casaburi R, Connett J, et al.
Chronic Obstr Pulm Dis
. 2022 Apr;
9(2):226-236.
PMID: 35403415
Introduction: Autonomic dysfunction is common in chronic obstructive pulmonary disease (COPD), and worse autonomic function may be a marker of risk for acute exacerbations of COPD (AECOPD). Heart rate variability...
6.
Parekh T, Helgeson E, Connett J, Voelker H, Ling S, Lazarus S, et al.
Ann Am Thorac Soc
. 2022 Apr;
19(10):1642-1649.
PMID: 35363600
The BLOCK COPD (β-Blockers for the Prevention of Acute Exacerbations of Chronic Obstructive Pulmonary Disease) study found that metoprolol was associated with a higher risk of severe exacerbation. To determine...
7.
Camac E, Voelker H, Criner G
Respir Med
. 2021 Jul;
186:106526.
PMID: 34229290
Rationale: Acute exacerbations negatively impact quality of life in patients with chronic obstructive pulmonary disease (COPD), but the impact of hospitalized exacerbations on quality of life is not clear. We...
8.
MacDonald D, Helgeson E, Adabag S, Casaburi R, Connett J, Stringer W, et al.
Ann Am Thorac Soc
. 2021 Mar;
18(11):1795-1802.
PMID: 33784233
The chronotropic index quantifies the proportion of the expected heart rate increase that is attained during exercise. The relationship between the chronotropic index and acute exacerbations of chronic obstructive pulmonary...
9.
Rao A, Del Carpio-Cano F, Janapati S, Zhao H, Voelker H, Lu X, et al.
J Thromb Haemost
. 2021 Feb;
19(7):1709-1717.
PMID: 33638931
Background: Statins are widely used to lower lipids and reduce cardiovascular events. In vitro studies and small studies in patients with hyperlipidemias show statins inhibit tissue factor (TF) and blood...
10.
Dransfield M, Voelker H, Bhatt S, Brenner K, Casaburi R, Come C, et al.
N Engl J Med
. 2019 Oct;
381(24):2304-2314.
PMID: 31633896
Background: Observational studies suggest that beta-blockers may reduce the risk of exacerbations and death in patients with moderate or severe chronic obstructive pulmonary disease (COPD), but these findings have not...